No headlines found.
Scinai Reports Nine-Month 2025 Results as CDMO Growth Continues and NanoAbs Pipeline Advances
PRNewswire (Tue, 2-Dec 8:50 AM ET)
Scinai Awarded Israel Innovation Authority Grant to Expand Fill-and-Finish CDMO Capabilities
PRNewswire (Mon, 6-Oct 7:30 AM ET)
Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units, one focused on in-house development of inflammation and immunology (I&I) biological therapeutic products beginning with a pipeline of nanosized VHH antibodies (NanoAbs) targeting diseases with large unmet medical needs, and the other a boutique CDMO providing services to help biotech companies efficiently bring their products to market by leveraging Scinai's drug development and GMP and non-GMP manufacturing capabilities for pre-clinical and clinical studies. The company generates maximum revenue from the provision of CDMO (Contract Development and Manufacturing Organization) services.
Scinai Immunotherapeutics Ltd. - American Depositary Shares trades on the NASDAQ stock market under the symbol SCNI.
As of December 18, 2025, SCNI stock price declined to $0.74 with 161,148 million shares trading.
SCNI has a beta of 1.42, meaning it tends to be more sensitive to market movements. SCNI has a correlation of 0.11 to the broad based SPY ETF.
SCNI has a market cap of $2.57 million. This is considered a Sub-Micro Cap stock.
The top ETF exchange traded funds that SCNI belongs to (by Net Assets): SPDW.
SCNI has underperformed the market in the last year with a price return of -78.2% while the SPY ETF gained +16.6%. SCNI has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -52.6% and -30.8%, respectively, while the SPY returned +2.7% and -1.2%, respectively.
SCNI support price is $.79 and resistance is $.91 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SCNI shares will trade within this expected range on the day.
